Among the PRLMGs, solute carrier family 7 member 7 (SLC7A7) and glycogen phosphorylase, liver form (PYGL) has been previously reported to be predictor of poor survival of GBM (49, 50). Here, SLC7A7 is linked to glioblastoma.